Skip to content

Brain Mechanisms of Reducing Polysubstance Use Following a Novel Body-mind Intervention

Brain Mechanisms of Reducing Polysubstance Use Following a Novel Body-mind Intervention

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04261504
Enrollment
70
Registered
2020-02-07
Start date
2019-04-19
Completion date
2023-02-28
Last updated
2024-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Drug Use

Brief summary

The proposed study will examine brain mechanisms of a brief mindfulness intervention - integrative body-mind training (IBMT) on alcohol, tobacco, and cannabis (ATC) reduction.

Detailed description

The R61 phase of the proposed study will examine brain mechanisms of a brief mindfulness intervention - integrative body-mind training (IBMT) that targets at self-control networks in the brain, and test IBMT effects on alcohol, tobacco, and cannabis (ATC) reduction.

Interventions

BEHAVIORALIBMT

mindful presence in a non-judgmental way

BEHAVIORALRT

progressive muscle relaxation

Sponsors

National Center for Complementary and Integrative Health (NCCIH)
CollaboratorNIH
Texas Tech University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 23 Years
Healthy volunteers
No

Inclusion criteria

* (1) at least 18 years old; * (2) free of any psychiatric diagnoses or medication (besides a substance use disorder to alcohol, tobacco, or cannabis); * (3) in the past month, at least 4 episode of heavy episodic drinking; at least 3 occasion of cannabis use; and daily cigarette use for at least the past month; * (4) normal or corrected-to-normal vision; * (5) written informed consent; * (6) no previous meditation or neurofeedback (NF) experiences.

Exclusion criteria

* (1) any psychiatric diagnoses other than a substance use disorder; * (2) medical disorder(s) that may affect the central nervous system; medications that affect the central and autonomic nervous system; or a positive pregnancy test result (females); * (3) excluding cannabis, evidence of recent (past month) illicit drug use.

Design outcomes

Primary

MeasureTime frameDescription
Brain Changes in Functional ActivityThe outcome measure is assessed at baseline and post-intervention.70 participants with polysubstance use are assessed by changes of brain in functional activity of anterior cingulate cortex before (baseline) and post-intervention (2 weeks).

Countries

United States

Participant flow

Participants by arm

ArmCount
Integrative Body Mind Training (IBMT)
mindfulness IBMT: mindful presence in a non-judgmental way
35
Relaxation Training (RT)
relaxation RT: progressive muscle relaxation
35
Total70

Baseline characteristics

CharacteristicIntegrative Body Mind Training (IBMT)Relaxation Training (RT)Total
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
35 Participants35 Participants70 Participants
Race/Ethnicity, Customized
Hispanic or Latino
11 Participants11 Participants22 Participants
Race/Ethnicity, Customized
Not Hispanic or Latino
24 Participants24 Participants48 Participants
Race/Ethnicity, Customized
Unknown/Not Reported Ethnicity
0 Participants0 Participants0 Participants
Sex: Female, Male
Female
17 Participants18 Participants35 Participants
Sex: Female, Male
Male
18 Participants17 Participants35 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 350 / 35
other
Total, other adverse events
0 / 350 / 35
serious
Total, serious adverse events
0 / 350 / 35

Outcome results

Primary

Brain Changes in Functional Activity

70 participants with polysubstance use are assessed by changes of brain in functional activity of anterior cingulate cortex before (baseline) and post-intervention (2 weeks).

Time frame: The outcome measure is assessed at baseline and post-intervention.

ArmMeasureGroupValue (MEAN)Dispersion
Integrative Body Mind Training (IBMT)Brain Changes in Functional ActivityBaseline0.7 beta weightsStandard Deviation 1.2
Integrative Body Mind Training (IBMT)Brain Changes in Functional ActivityPost-Intervention1.3 beta weightsStandard Deviation 1.1
Relaxation Training (RT)Brain Changes in Functional ActivityBaseline0.6 beta weightsStandard Deviation 1.3
Relaxation Training (RT)Brain Changes in Functional ActivityPost-Intervention0.9 beta weightsStandard Deviation 2.2
p-value: 0.03threshold-free cluster enhancement

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026